Allspring Global Investments Holdings, LLC Axonics, Inc. Transaction History

Allspring Global Investments Holdings, LLC

$62.1 Billion
Q3 2024

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 18, 2024	SELL	$56.67 - $69.36 $28,505 - $34,888	-503 Reduced 1.02%	48,769 $3.36 Million
Q4 2023 Jan 25, 2024	BUY	$49.38 - $63.75 $157,127 - $202,852	3,182 Added 6.9%	49,272 $3.07 Million
Q3 2023 Oct 27, 2023	BUY	$48.64 - $62.51 $2.24 Million - $2.88 Million	46,090 New	46,090 $2.59 Million
Q2 2023 Jul 18, 2023	SELL	$47.99 - $60.21 $8.04 Million - $10.1 Million	-167,503 Reduced 52.07%	154,196 $7.78 Million
Q1 2023 Apr 13, 2023	SELL	$52.6 - $67.34 $7.64 Million - $9.79 Million	-145,317 Reduced 31.12%	321,699 $17.6 Million
Q4 2022 Jan 23, 2023	BUY	$59.56 - $76.6 $5.24 Million - $6.74 Million	87,989 Added 23.21%	467,016 $0
Q3 2022 Oct 26, 2022	SELL	$57.96 - $78.12 $2.06 Million - $2.78 Million	-35,558 Reduced 8.58%	379,027 $26.7 Million
Q2 2022 Jul 25, 2022	SELL	$39.5 - $64.42 $4.99 Million - $8.13 Million	-126,271 Reduced 23.35%	414,585 $23.5 Million
Q1 2022 May 02, 2022	SELL	$43.74 - $62.76 $285,184 - $409,195	-6,520 Reduced 1.19%	540,856 $33.9 Million
Q4 2021 Jan 28, 2022	BUY	$50.01 - $73.35 $27.4 Million - $40.2 Million	547,376 New	547,376 $30.7 Million

Others Institutions Holding AXNX

# of Institutions

233

Shares Held

42.1M

Call Options Held

83.4K

Put Options Held

65.3K

Vanguard Group Inc Valley Forge, PA

5.06M
Shares

$359 Million
0.01% of portfolio
Black Rock Inc. New York, NY

4.34M
Shares

$308 Million
0.01% of portfolio
Alpine Associates Management Inc. Englewood Cliffs, NJ

2.18M
Shares

$155 Million
6.99% of portfolio
Fil LTD Hamilton, D0

2.04M
Shares

$145 Million
0.14% of portfolio
Westchester Capital Management, LLC Valhalla, NY

1.45M
Shares

$103 Million
4.89% of portfolio

View Full List

About Axonics, Inc.

Ticker AXNX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 49,123,600
Market Cap $3.49B
Description
Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...

More about AXNX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Allspring Global Investments Holdings, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Allspring Global Investments Holdings, LLC with notifications on news.

Account